RENX — Renalytix Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Renalytix, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2020 June 30th	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	14.3	74.5	44.2	26.3	5.46
Net Total Accounts Receivable
Net Total Receivables	0.018	0.594	0.901	0.776	0.722
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	18.9	76	47.4	28.3	6.81
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.945	1.38	1.72	1.22	0.213
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	41.3	103	63.3	42.1	7.1
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	5.34	7.26	12.2	16.1	11.7
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	5.34	7.48	20.1	23.7	16.1
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	36	95.1	43.2	18.5	-8.98
Total Liabilities & Shareholders' Equity	41.3	103	63.3	42.1	7.1
Total Common Shares Outstanding